Jubilant Pharmova LtdPharmaceuticalsINE700A01033Consolidated₹1065.40+53.30 (+5.27%)Jun-26
Valuation
Market Cap₹16.97K Cr
TTM PE47.93x
Forward PE54.58x
PEG-4.13
Book Value₹445.30
P/B2.39x
TTM EPS₹22.23
Fwd EPS₹19.52
TTM Revenue₹8.61K Cr
TTM PAT₹351.40 Cr
TTM EBITDA₹1.22K Cr
TTM EBIT₹748.60 Cr
Last Qtr PAT₹56.40 Cr
Last Qtr EBITDA₹248.00 Cr
Last Qtr EBIT₹120.70 Cr
Profitability
ROE4.95%
ROCE7.17%
TTM NPM4.08%
TTM EBITDA %14.15%
Curr OPM2.51%
Last OPM5.16%
Curr NPM
Last NPM
Curr EPS₹3.57
Last EPS₹7.55
Balance sheet
Equity₹15.80 Cr
Reserve₹7.08K Cr
Total Debt₹3,547.70 Cr
D/E0.50x
Interest %96.10%
Curr Interest₹54.20 Cr
Price / range
Close₹1065.40
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D+5.27%
1W+3.92%
1M+23.03%
3M+9.45%
6M+24.36%
1Y-4.44%
2Y-11.14%
3Y+141.18%
5Y+73.42%
Diwali+0.90%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue67.10+12.8%70.3067.3066.4059.50263.50
Other Income0.100.500.400.800.702.40
Total Income67.20+11.6%70.8067.7067.2060.20265.90
Interest0.900.900.902.5037.30
Expenditure-57.40-6.9%-58-57.60-58.70-53.70-228
PBDT000000
EBITDA12+16.5%14.5012.2011.8010.3048.80
Depreciation-1.40-1.30-1.60-1.60-1.50-6
EBIT10.60+20.5%13.2010.6010.208.8042.80
PBT9.80+50.8%4.1010.108.506.5029.20
Tax-2.5053.10-3.50-56.50-2.40-9.30
Equity15.9015.9015.90015.9015.90
OPM14.585.7914.9212.8010.8010.98
Net Profit7.30+25.9%57.206.60-6.405.8063.20
NPM10.8680.799.75-9.649.6323.77
EPS0.46+76.9%3.590.422.620.263.97

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue263.50-64.7%745.70-5.0%784.70-3.1%810.12+823.2%87.75-96.8%2,709.50
Other Income2.4099.60103.40137.89125.8747.88
Total Income265.90-68.5%845.30-4.8%888.10-6.3%948.01+343.8%213.62-92.3%2,757.38
Expenditure-228+71.4%-796.50+5.9%-846.40+2.6%-868.67-561.2%-131.37+94.7%-2,484.21
Interest-7.30-29.80-29.90-18.52-30.59-101.80
PBDT000000
EBITDA48.80+52.0%32.10+94.5%16.50+412.4%3.22+147.5%-6.78-101.6%427.06
Depreciation-6-53.10-48.30-43.25-6.25-99.97
EBIT42.80+303.8%-21+34.0%-31.80+20.6%-40.03-207.2%-13.03-104.0%327.09
PBT29.20-22.3%37.60-9.8%41.70-47.4%79.34-3.5%82.25-69.9%273.17
Tax-9.30-18.40-10.10-29.46-3.75-58.69
Equity15.9015.900000
OPM (%)10.984.455.008.0039.0010.00
Net Profit63.20+229.2%19.20-39.2%31.60-36.6%49.88-36.5%78.50-63.4%214.48
NPM (%)23.772.274.005.0037.008.00
EPS (Rs)3.97+228.1%1.21-39.2%1.99-36.4%3.13-36.5%4.93-63.4%13.47
CEPS3.971.211.993.134.9313.47

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue2,229.40+17.3%2,2902,122.501,966.401,900.708,279.60
Other Income19.9023.7020.509.801266
Total Income2,249.30+17.6%2,313.702,1431,976.201,912.708,345.60
Interest54.2056.5056.1050.2049211.80
Expenditure-2,162.90-23.0%-2,124-2,009.80-1,780-1,758.20-7,672
PBDT000000
EBITDA248-14.4%339.30289.50341.40289.601,259.80
Depreciation-127.30-116.80-120.70-104.80-98.10-440.40
EBIT120.70-37.0%222.50168.80236.60191.50819.40
PBT86.40-44.1%17693.50190.40154.50614.40
Tax-30-56.70-37.60-70.40-51.90-216.60
Equity15.8015.800015.8015.80
OPM3.847.614.369.638.087.36
Net Profit56.40-45.0%119.3055.80119.90102.50397.50
NPM2.515.162.606.075.364.76
EPS3.57-45.0%7.553.527.596.4925.15

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 21-22FY 20-21FY 19-20
Revenue8,279.60+14.4%7,234.50+979.3%670.296,059.17-0.6%6,098.54-33.4%9,154.41
Other Income6656.806.8782.2817.6447.43
Total Income8,345.60+14.5%7,291.30+976.7%677.166,141.45+0.4%6,116.18-33.5%9,201.84
Expenditure-7,672-15.0%-6,669.70-933.1%-645.63-5,501.02-5.1%-5,235.12+34.2%-7,956.67
Interest-211.80-240.30-27.23-145.49-184.10-287.41
PBDT000000
EBITDA1,259.80+7.3%1,173.70+1203.0%90.081,085.34-22.3%1,396.47-28.3%1,947.08
Depreciation-440.40-368.60-38.19-381.70-348.95-461.93
EBIT819.40+1.8%805.10+1451.6%51.89703.64-32.8%1,047.52-29.5%1,485.15
PBT614.40-37.4%981.10+6601.5%14.64640.43-25.5%859.83-29.0%1,210.53
Tax-216.60-144.30-9.78-217.43-297.22-312.29
Equity15.8015.800000
OPM (%)7.3613.462.1610.4314.0613.16
Net Profit397.50-52.5%836.30+11403.4%7.27413.02-50.6%835.61-7.0%898.24
NPM (%)4.7611.471.076.7313.669.76
EPS (Rs)25.15-52.5%52.99+988.1%4.8726-50.5%52.48-6.9%56.39
CEPS25.0852.854.862652.4856.39

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

19
YearTypeAmountEx-Date
2026Final Dividend524 Jul 2026
2025Final Dividend525 Jul 2025
2024Final Dividend502 Aug 2024
2023Final Dividend510 Aug 2023
2022Final Dividend511 Aug 2022
2021Final Dividend505 Aug 2021
2020Interim Dividend509 Mar 2020
2019Final Dividend4.512 Sep 2019
2018Final Dividend312 Sep 2018
2017Final Dividend316 Aug 2017
2016Final Dividend318 Aug 2016
2015Final Dividend320 Aug 2015
2014Final Dividend321 Aug 2014
2013Final Dividend314 Aug 2013
2012Final Dividend314 Aug 2012
2011Final Dividend210 Aug 2011
2010Final Dividend217 Sep 2010
2009Final Dividend1.529 Jun 2009
2008Final Dividend1.517 Sep 2008

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers